Header Logo

Connection

JORGE CASTILLO to Drug Synergism

Back to Details
This is a "connection" page, showing publications JORGE CASTILLO has written about Drug Synergism.
JORGE CASTILLO
Connection Strength
0.029
Drug Synergism
  1. The BCL2 antagonist ABT-199 triggers apoptosis, and augments ibrutinib and idelalisib mediated cytotoxicity in CXCR4 Wild-type and CXCR4 WHIM mutated Waldenstrom macroglobulinaemia cells. Br J Haematol. 2015 Jul; 170(1):134-8.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.